Calculate trailing & forward P/E, assess market valuation relative to industry, and compute the PEG ratio. Interactive gauge visualizes undervalued to overvalued zones.
The Price-to-Earnings (P/E) ratio is the most widely used stock valuation metric. It tells you how much investors are willing to pay for each dollar of earnings. A high P/E may indicate growth expectations, while a low P/E can signal undervaluation or fundamental issues. Our calculator goes further by integrating the PEG ratio (P/E divided by earnings growth rate), offering a growth-adjusted perspective popularized by legendary investor Peter Lynch.
| Sector | Typical P/E Range | Notes |
|---|---|---|
| Technology | 20–35x | High growth multiples |
| Consumer Staples | 15–20x | Defensive & stable earnings |
| Financials/Banks | 10–15x | Interest rate sensitive |
| Healthcare | 16–22x | Moderate growth, R&D intensive |
| Energy | 8–14x | Cyclical commodity exposure |
Company A trades at P/E = 32x with EPS growth 24% → PEG = 1.33 (slightly expensive). Company B trades at P/E = 28x with growth 30% → PEG = 0.93 (attractive). Despite a lower absolute P/E for B, the PEG reveals superior growth-adjusted value. Our calculator instantly computes the PEG ratio, helping investors avoid value traps and growth-at-reasonable-price (GARP) opportunities.
P/E alone can be misleading. Negative earnings produce meaningless ratios; cyclical companies show artificially low P/E during booms. Always combine with other metrics: EV/EBITDA, P/B, dividend yield, and free cash flow yield. For companies with negative earnings, we recommend using our Price/Sales Ratio or EV/EBITDA tools (available in the Finance category). The website Professor Aswath Damodaran (NYU) provides extensive global P/E data – our calculator’s fair zone (10–30x) is derived from historical US market averages (1920–2024).
Data references: Robert Shiller’s CAPE dataset (Yale), Damodaran’s annual multiples update. The calculator logic follows CFA Institute guidelines for equity valuation. All computations double-precision, validated against Bloomberg terminal outputs. Last reviewed April 2026 by the GetZenQuery tech team including former equity analysts.